Allogene Therapeutics Q2 2025 Earnings Preview

3 hours ago 1
  • Allogene Therapeutics (NASDAQ:ALLO) is scheduled to announce Q2 earnings results on Wednesday, August 13th, after market close.
  • The consensus EPS Estimate is -$0.27 (+22.9% Y/Y)
  • Over the last 1 year, ALLO has beaten EPS estimates 50% of the time and has

Recommended For You

More Trending News

Read Entire Article